In endometrial stromal sarcomas, Jazf1–SUZ12 rearrangement exacerbates cancer through inhibiting the PRC2 complex, thereby lowering histone methyl transferase expression [19]. This evidence concerns the gene PRDM9 and endometrioid stromal sarcoma.